Last updated: September 28, 2023
Sponsor: Centre Hospitalier Universitaire de la Réunion
Overall Status: Active - Recruiting
Phase
N/A
Condition
Neoplasms
Cancer (Pediatric)
Treatment
Virtual reality headset
Clinical Study ID
NCT05592132
2022/CHU/11
Ages 6-18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- patient who tolerates the virtual reality headset
- patient followed in pediatric oncology
- patient with a diagnosis of benign tumor or cancer
- patient who needs to have painful medical procedure during their treatment
- patient whose parents have signed the informed consent
- patient affiliated with social security or equivalent
Exclusion
Exclusion Criteria:
- patient with visual or hearing impairement
- patient with epilepsy or other neurological disease
- patient with psychiatric disease
Study Design
Total Participants: 74
Treatment Group(s): 1
Primary Treatment: Virtual reality headset
Phase:
Study Start date:
January 17, 2023
Estimated Completion Date:
October 31, 2025
Connect with a study center
CHU de La Réunion
Saint-Denis, 97400
RéunionActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.